BNP Paribas Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Buy |
|
|||||
|
2025
Q1 | $68.1M | Buy |
|
|||||
|
2024
Q4 | $61M | Buy |
|
|||||
|
2024
Q3 | $47.8M | Sell |
|
|||||
|
2024
Q2 | $46.8M | Sell |
|
|||||
|
2024
Q1 | $57.5M | Sell |
|
|||||
|
2023
Q4 | $87.7M | Sell |
|
|||||
|
2023
Q3 | $98.8M | Sell |
|
|||||
|
2023
Q2 | $96.8M | Sell |
|
|||||
|
2023
Q1 | $133M | Sell |
|
|||||
|
2022
Q4 | $147M | Buy |
|
|||||
|
2022
Q3 | $94.4M | Buy |
|
|||||
|
2022
Q2 | $99.2M | Buy |
|
|||||
|
2022
Q1 | $91.6M | Sell |
|
|||||
|
2021
Q4 | $88.5M | Buy |
|
|||||
|
2021
Q3 | $76.6M | Buy |
|
|||||
|
2021
Q2 | $93M | Buy |
|
|||||
|
2021
Q1 | $78.8M | Buy |
|
|||||
|
2020
Q4 | $75.6M | Sell |
|
|||||
|
2020
Q3 | $73.9M | Buy |
|
|||||
|
2020
Q2 | $52.4M | Buy |
|
|||||
|
2020
Q1 | $44.5M | Buy |
|
|||||
|
2019
Q4 | $51.5M | Buy |
|
|||||
|
2019
Q3 | $41.9M | Buy |
|
|||||
|
2019
Q2 | $44M | Buy |
|
|||||
|
2019
Q1 | $39.4M | Sell |
|
|||||
|
2018
Q4 | $33.8M | Sell |
|
|||||
|
2018
Q3 | $49.9M | Buy |
|
|||||
|
2018
Q2 | $40M | Sell |
|
|||||
|
2018
Q1 | $41.3M | Sell |
|
|||||
|
2017
Q4 | $37.2M | Sell |
|
|||||
|
2017
Q3 | $46.9M | Buy |
|
|||||
|
2017
Q2 | $48.1M | Buy |
|
|||||
|
2017
Q1 | $40M | Sell |
|
|||||
|
2016
Q4 | $32.5M | Sell |
|
|||||
|
2016
Q3 | $37.1M | Buy |
|
|||||
|
2016
Q2 | $40.9M | Buy |
|
|||||
|
2016
Q1 | $6.27M | Sell |
|
|||||
|
2015
Q4 | $6.79M | Sell |
|
|||||
|
2015
Q3 | $7.66M | Buy |
|
|||||
|
2015
Q2 | $9.43M | Buy |
|